[{"address1": "1500 Broadway", "address2": "Suite 1401", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "332 208 6102", "website": "https://www.nuvationbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a BD2 selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform which leverages a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies to deliver anti-cancer therapeutics to cancer cells, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 51, "companyOfficers": [{"maxAge": 1, "name": "Dr. David T. Hung M.D.", "age": 65, "title": "Founder, President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": 944509, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David C. Hanley Ph.D.", "age": 53, "title": "Chief Technical Operations Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 586040, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Moses  Makunje", "age": 44, "title": "Principal Accounting Officer & Principal Financial Officer", "yearBorn": 1979, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Hattersley Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 687881, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy  Markel", "age": 58, "title": "Chief People Officer", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kerry A. Wentworth", "age": 50, "title": "Chief Regulatory Officer", "yearBorn": 1973, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Liu M.D., Ph.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.48, "open": 3.48, "dayLow": 3.27, "dayHigh": 3.51, "regularMarketPreviousClose": 3.48, "regularMarketOpen": 3.48, "regularMarketDayLow": 3.27, "regularMarketDayHigh": 3.51, "beta": 1.192, "forwardPE": -6.0925922, "volume": 2044495, "regularMarketVolume": 2044495, "averageVolume": 1244006, "averageVolume10days": 3759920, "averageDailyVolume10Day": 3759920, "bid": 3.27, "ask": 3.29, "bidSize": 1400, "askSize": 3200, "marketCap": 720661312, "fiftyTwoWeekLow": 0.95, "fiftyTwoWeekHigh": 4.16, "fiftyDayAverage": 2.1992, "twoHundredDayAverage": 1.67387, "currency": "USD", "enterpriseValue": 262407488, "floatShares": 122882738, "sharesOutstanding": 218046000, "sharesShort": 2820950, "sharesShortPriorMonth": 2599686, "sharesShortPreviousMonthDate": 1707955200, "dateShortInterest": 1710460800, "sharesPercentSharesOut": 0.0128999995, "heldPercentInsiders": 0.26995, "heldPercentInstitutions": 0.62011003, "shortRatio": 3.45, "shortPercentOfFloat": 0.0238, "impliedSharesOutstanding": 219046000, "bookValue": 2.763, "priceToBook": 1.1907347, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -75802000, "trailingEps": -0.35, "forwardEps": -0.54, "enterpriseToEbitda": -2.635, "52WeekChange": 0.8693181, "SandP52WeekChange": 0.26653707, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "NUVB", "underlyingSymbol": "NUVB", "shortName": "Nuvation Bio Inc.", "longName": "Nuvation Bio Inc.", "firstTradeDateEpochUtc": 1598448600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "292fc361-56ab-3994-b08a-1a4c45c2f81b", "messageBoardId": "finmb_639036735", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.29, "targetHighPrice": 10.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.7, "targetMedianPrice": 5.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 611212992, "totalCashPerShare": 2.79, "ebitda": -99600000, "totalDebt": 4007000, "quickRatio": 44.004, "currentRatio": 44.113, "debtToEquity": 0.662, "returnOnAssets": -0.09646, "returnOnEquity": -0.120299995, "freeCashflow": -41592752, "operatingCashflow": -67999000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-07"}]